Form 8-K · Current report
Bio-Techne 8-K, filed Nov 4, 2026
- Filed
- CIK
- 0000842023
- Accession no.
- 0001104659-26-122283
Summary
Bio-Techne's board of directors declared a quarterly cash dividend of $0.08 per share for the quarter ended September 30, 2026, payable November 23, 2026 to shareholders of record as of November 13, 2026, provided the company's pending acquisition by Merck KGaA has not closed by that record date.
Key points
- The dividend is $0.08 per share for the quarter ended September 30, 2026.
- It is payable November 23, 2026 to common shareholders of record at the close of business on November 13, 2026.
- Payment is contingent on Bio-Techne's previously announced transaction with Merck KGaA, Darmstadt, Germany not having closed on or before November 13, 2026.
- Bio-Techne reported over $1.2 billion in net sales in fiscal 2026 and approximately 3,000 employees worldwide.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events A copy of the press release issued by Bio-Techne Corporation on November 3, 2026, announcing a cash dividend is attached hereto as Exhibit 99.1. Item 9.01 Financial Statements and Exhibits (d) Exhibits 99.1 Press Release, dated November 3, 2026, announcing cash dividend 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Exhibit 99.1: EX-99.1 2 tech-ex99d1.htm EX-99.1 Exhibit 99.1 BIO-TECHNE DECLARES DIVIDEND MINNEAPOLIS, November 3, 2026/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.